Table 1.

Baseline characteristics of randomised participants

Characteristics	TCV (N=10,005)	Men A (N=10 014)	Total (N= 20019)
Gender
Male N (%)	5106 (51.0%)	5158 (51.5%)	10264 (51.3%)
Age at enrolment (years)
Mean (SD)	7.9 (4.1)	7.8 (4.0)	7.9 (4.1)
Median [Range]	7.7 [0.8 – 16.1]	7.7 [0.7 – 16.1]	7.7 [0.7 – 16.1] *
< 5 years N (%)	2907 (29.1%)	2905 (29.0%)
≥ 5 years N (%)	7098 (70.9%)	7109 (71.0%)
Self-reported medical history of Typhoid fever**
N (%)	345 (3.5%)	395 (4.0%)	740 (3.7%)

^*6 participants are outside the age range for eligibility (9 months to 15 years + 364 days)

^**Self-reported history of typhoid infection prior to the beginning of the study, reported at baseline intake

TCV = Typhoid Conjugate Vaccine. Men A = Group A meningococcal vaccine (control)